Pierce Christopher purchased ~$77M in Prelude Therapeutics Incorporated stock
Prelude Therapeutics Incorporated (PRLD) · EVP and Chief of Business Oper · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
+239.5%vs SPY +12.7%
Trade Details · Public SEC Filing
Insider
Pierce Christopher
Role
EVP and Chief of Business Oper
Transaction
Open-Market Purchase
Approx. Value
~$77M
Trade Date
Sep 25, 2020
Company
Prelude Therapeutics Incorporated
Ticker
PRLDSource
SEC EDGAR Form 4
Why This Trade Stands Out
Very Strong conviction signal
Scored in the top tier across multiple factors. Fewer than 5% of insider trades receive this rating.
~$77M purchase
Trades over $1M are rare. When insiders put this much of their own money on the line, they tend to have high conviction in their company's direction.
EVP and Chief of Business Oper
Senior executives have visibility into their division's pipeline and company health. Their trades carry weight because they understand the business from the inside.
7 insiders traded in the same window
When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.
+239.5% in 90 days (S&P 500: +12.7%)
This trade beat the S&P 500 by 226.7 percentage points over 90 days. We track performance on every insider trade so you can see who consistently outperforms.
How good is Pierce Christopher at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
Pierce Christopher wasn't the only one buying.
7 insiders at Prelude Therapeutics Incorporated traded within the same 30-day window.
See who else bought · FreeOn September 25, 2020, Pierce Christopher — EVP and Chief of Business Oper of Prelude Therapeutics Incorporated — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$77M in Prelude Therapeutics Incorporated (PRLD) stock.
This transaction was part of a cluster — 7 insiders at Prelude Therapeutics Incorporated made open-market purchases within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, PRLD returned +239.5% versus +12.7% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Pierce Christopher trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More PRLD Insider Activity
ORBIMED ADVISORS LLC
Apr 21, 2026
~$7.5M
VS
Bonita David P
Apr 21, 2026
~$5.0M
VS
Bonita David P
Apr 21, 2026
~$7.5M
VS
ORBIMED ADVISORS LLC
Apr 21, 2026
~$5.0M
VS
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free